Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Gross Margin (2016 - 2025)

Historic Gross Margin for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 56.38%.

  • Angiodynamics' Gross Margin rose 16000.0% to 56.38% in Q4 2025 from the same period last year, while for Nov 2025 it was 54.58%, marking a year-over-year increase of 18700.0%. This contributed to the annual value of 53.92% for FY2025, which is 30100.0% up from last year.
  • Per Angiodynamics' latest filing, its Gross Margin stood at 56.38% for Q4 2025, which was up 16000.0% from 55.29% recorded in Q3 2025.
  • Angiodynamics' 5-year Gross Margin high stood at 56.38% for Q4 2025, and its period low was 47.7% during Q1 2024.
  • Its 5-year average for Gross Margin is 52.79%, with a median of 52.72% in 2022.
  • As far as peak fluctuations go, Angiodynamics' Gross Margin crashed by -36200bps in 2021, and later surged by 62700bps in 2025.
  • Angiodynamics' Gross Margin (Quarter) stood at 51.81% in 2021, then rose by 2bps to 52.77% in 2022, then dropped by -4bps to 50.92% in 2023, then rose by 8bps to 54.78% in 2024, then grew by 3bps to 56.38% in 2025.
  • Its last three reported values are 56.38% in Q4 2025, 55.29% for Q3 2025, and 52.67% during Q2 2025.